Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
New Ray Medicine International Holding Ltd. ( (HK:6108) ) just unveiled an announcement.
New Ray Medicine International Holding Ltd. has announced that its board of directors will meet on March 25, 2025, to discuss and approve the final results for the year ending December 31, 2024. The meeting will also consider the payment of a final dividend, which could impact the company’s financial outlook and shareholder returns.
More about New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Ltd. is a company incorporated in Bermuda with limited liability, focusing on the pharmaceutical industry. The company, along with its subsidiaries, is involved in the development and distribution of medical products.
YTD Price Performance: 10.0%
Average Trading Volume: 2,084,371
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$73.56M
See more data about 6108 stock on TipRanks’ Stock Analysis page.